Source: BioPortfolio

Pulmagen Therapeutics: Pulmagen Therapeutics LLP Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14032018 Prices from USD $250

SummaryPulmagen Therapeutics LLP Pulmagen formerly Argenta Discovery Ltd is a development stage pharmaceutical company which develops oral and inhaled medicines for chronic respiratory diseases. The company's product pipeline includes oral CRTh2 antagonist...

Read full article »
Pulmagen Therapeutics's Competitors | Pulmagen Therapeutics's News | Pulmagen Therapeutics's Financials
Stay up-to-date with the latest news on Pulmagen Therapeutics
Est. Annual Revenue
$100K-5.0M
Est. Employees
250-500
Christopher Philip Ashton's photo - CEO of Pulmagen Therapeutics

CEO

Christopher Philip Ashton

CEO Approval Rating

69/100

Read more
Stay up-to-date with the latest news on Pulmagen Therapeutics